The effect of timing of teriparatide treatment on the circadian rhythm of bone turnover in postmenopausal osteoporosis

European Journal of Endocrinology

Volumn 164, Issue 4, 2011, Pages 643-648

  Luchavova, Maria ^a   Zikan, Vit ^a   Michalska, Dana ^a   Raska Jr , Ivan ^a   Kubena, Ales A ^b   Stepan, Jan J ^c  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF INFORMATION THEORY AND AUTOMATION   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CARBOXY TERMINAL TELOPEPTIDE; PARATHYROID HORMONE; PARATHYROID HORMONE[1-34]; PROCOLLAGEN C PROTEINASE; AMINO TERMINAL TELOPEPTIDE; BIOLOGICAL MARKER; COLLAGEN TYPE 1;

ADULT; AGED; ARTICLE; BONE REMODELING; BONE TURNOVER; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; DOSAGE SCHEDULE COMPARISON; DOSE RESPONSE; DRUG EFFICACY; EVENING DOSAGE; FEMALE; HUMAN; MORNING DOSAGE; OSTEOLYSIS; PARATHYROID HORMONE BLOOD LEVEL; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; BONE DENSITY; CALCIUM BLOOD LEVEL; COLLAGEN DEGRADATION; COLLAGEN SYNTHESIS; DOSE TIME EFFECT RELATION; DRUG EFFECT; LONG TERM CARE; METABOLIC REGULATION; TREATMENT DURATION; WOMEN'S HEALTH;

AGED; AGED, 80 AND OVER; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; CIRCADIAN RHYTHM; FEMALE; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; TERIPARATIDE;

EID: 79953206988     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-10-1108     Document Type: Article

References (21)

1. Wichers M, Schmidt E, Bidlingmaier F & Klingmüller D. Diurnal rhythm of CrossLaps in human serum. Clinical Chemistry 1999 45 1858-1860. (Pubitemid 29477347)
2. Qvist P, Christgau S, Pedersen BJ, Schlemmer A & Christiansen C. Circadian variation in the serum concentration of C-terminal telopeptide of type I collagen (serum CTx): effects of gender, age, menopausal status, posture, daylight, serum cortisol, and fasting. Bone 2002 31 57-61. (doi:10.1016/S8756- 3282(02)00791-3)
3. Eastell R, Calvo MS, Burritt MF, Offord KP, Russell RG & Riggs BL. Abnormalities in circadian patterns of bone resorption and renal calcium conservation in type I osteoporosis. Journal of Clinical Endocrinology and Metabolism 1992 74 487-494. (doi:10.1210/jc.74.3.487)
4. Nielsen HK, Brixen K, Kassem M, Charles P & Mosekilde L. Inhibition of the morning cortisol peak abolishes the expected morning decrease in serum osteocalcin in normal males: evidence of a controlling effect of serum cortisol on the circadian rhythm in serum osteocalcin. Journal of Clinical Endocrinology and Metabolism 1992 74 1410-1414. (doi:10.1210/jc.74.6.1410)
5. Ahmad AM, Hopkins MT, Fraser WD, Ooi CG, Durham BH & Vora JP. Parathyroid hormone secretory pattern, circulating activity, and effect on bone turnover in adult growth hormone deficiency. Bone 2003 32 170-179. (doi:10.1016/S8756-3282(02)00952-3)
6. Schlemmer A, Hassager C, Alexandersen P, Fledelius C, Pedersen BJ, Kristensen IO & Christiansen C. Circadian variation in bone resorption is not related to serum cortisol. Bone 1997 21 83-88. (doi:10.1016/S8756-3282(97) 00039-2)
7. Schlemmer A, Ravn P, Hassager C & Christiansen C. Morning or evening administration of nasal calcitonin? Effects on biochemical markers of bone turnover Bone 1997 20 63-67. (doi:10.1016/S8756-3282(96)00307-9)
8. el-Hajj Fuleihan G, Klerman EB, Brown EN, Choe Y, Brown EM & Czeisler CA. The parathyroid hormone circadian rhythm is truly endogenous - a general clinical research center study. Journal of Clinical Endocrinology and Metabolism 1997 82 281-286. (doi:10.1210/jc.82.1.281)
9. Joseph F, Chan BY, Durham BH, Ahmad AH, Vinjamin S, Gallagher JA, Vora JP & Fraser WD. The circadian rhythm of osteoprotegerin and its association with parathyroid hormone secretion. Journal of Clinical Endocrinology and Metabolism 2007 92 3230-3238. (doi:10.1210/jc.2007-0812)
10. Blumsohn A, Herrington K, Hannon RA, Shao P, Eyre DR & Eastell R. The effect of calcium supplementation on the circadian rhythm of bone resorption. Journal of Clinical Endocrinology and Metabolism 1994 79 730-735. (doi:10.1210/jc.79.3.730)
11. Ledger GA, Burritt MF, Kao PC, O'Fallon WM, Riggs BL & Khosla S. Role of parathyroid hormone in mediating nocturnal and age-related increases in bone resorption. Journal of Clinical Endocrinology and Metabolism 1995 80 3304-3310. (doi:10.1210/jc.80.11.3304)
12. Fraser WD, Logue FC, Christie JP, Cameron DA, O'Reilly DS & Beastall GH. Alteration of the circadian rhythm of intact parathyroid hormone following a 96-hour fast. Clinical Endocrinology 1994 40 523-528. (doi:10.1111/j.1365-2265. 1994.tb02493.x)
13. Fraser WD, Logue FC, Christie JP, Gallacher SJ, Cameron D, O'Reilly DS, Beastall GH & Boyle IT. Alteration of the circadian rhythm of intact parathyroid hormone and serum phosphate in women with established postmenopausal osteoporosis. Osteoporosis International 1998 8 121-126. (doi:10.1007/ BF02672507)
14. Ledger GA, Burritt MF, Kao PC, O'Fallon WM, Riggs BL & Khosla S. Abnormalities of parathyroid hormone secretion in elderly women that are reversible by short term therapy with 1,25-dihydroxyvitamin D3. Journal of Clinical Endocrinology and Metabolism 1994 79 211-216. (doi:10.1210/jc.79.1.211)
15. Dobnig H & Turner RT. The effects of programmed administration of human parathyroid hormone fragment (1-34) on bone histomorphometry and serum chemistry in rats. Endocrinology 1997 138 4607-4612. (doi:10.1210/en.138.11. 4607)
16. Calvo MS, Eastell R, Offord KP, Bergstralh EJ & Burritt MF. Circadian variation in ionized calcium and intact parathyroid hormone: evidence for sex differences in calcium homeostasis. Journal of Clinical Endocrinology and Metabolism 1991 72 69-76. (doi:10.1210/jcem-72-1-69)
17. Nielsen HK, Brixen K, Kassem M, Christensen SE & Mosekilde L. Diurnal rhythm in serum osteocalcin: relation with sleep, growth hormone, and PTH(1-84). Calcified Tissue International 1991 49 373-377. (doi:10.1007/ BF02555845)
18. Onyia JE, Miles RR, Yang X, Halladay DL, Hale J, Glasebrook A, McClure D, Seno G, Churgay L, Chandrasekhar S & Martin TJ. In vivo demonstration that human parathyroid hormone 1-38 inhibits the expression of osteoprotegerin in bone with the kinetics of an immediate early gene. Journal of Bone and Mineral Research 2000 15 863-871. (doi:10.1359/jbmr.2000.15.5.863)
19. Ma YL, Cain RL, Halladay DL, Yang X, Zeng Q, Miles RR, Chandrasekhar S & Martin TJ& Onyia JE. Catabolic effects of continuous human PTH (1-38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation. Endocrinology 2001 142 4047-4054. (doi:10.1210/en.142.9.4047)
20. Clowes JA, Hannon RA, Yap TS, Hoyle NR, Blumsohn A & Eastell R. Effect of feeding on bone turnover markers and its impact on biological variability of measurements. Bone 2002 30 886-890. (doi:10.1016/S8756-3282(02) 00728-7)
21. Bjarnason NH, Henriksen EE, Alexandersen P, Christgau S, Henriksen DB & Christiansen C. Mechanism of circadian variation in bone resorption. Bone 2002 30 307-313. (doi:10.1016/S8756-3282(01)00662-7)